Bristol-Myers Squibb Co (BMY) P/FCF 9.3 | Overview

Search global stocks & ETFs...Ctrl K

Learn Mode

Bristol-Myers Squibb CoBMY

$54.00

-$1.28 (-2.315%)

at close

$54.05

$0.05 (0.093%)

after hours · 9:17 PM

3.85/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

Updates

BMY

Stock Profile

Market Cap

Industry

EPS (TTM)

P/E (TTM)

Div & Yield

FCF Payout Ratio

P/S (TTM)

P/B

Revenue Growth (TTM)

EPS CAGR (3Y)

Diluted Shares

Ex-Dividend

Next Earnings

Forward P/E

Payout Ratio

P/FCF (TTM)

FCF Yield

Earnings Yield

Revenue CAGR (3Y)

Recommended Metric

Score Card

Explore Scores Tab

3.85

Good

Bristol-Myers Squibb Co has seen its revenue decline by -23.83% over the past year, which means the company is losing sales/customers. However, it has seen its operating income increase by 14.01% over the past year, which suggests its operations are becoming much more profitable.

Valuation Score

Key Score

1.00

Very Bad

Management

5.00

Very Good

Growth

5.00

Very Good

Profitability

2.00

Bad

Fin. Health

3.00

Average

Dividends

1.00

Very Bad

Analyst

4.00

Good

Financials

Explore Financial Tab ›

Revenue

Earnings

Free Cash Flow

Insider Transactions

Explore Insider Tab ›

Buy Transactions

Sell Transactions

Peers

Select stocks to compare

AXSMAxsome Therapeutics Inc

RPRXRoyalty Pharma Plc

ELANElanco Animal Health Inc

Price Targets & Ratings

View Analysis

1-year price targets, ending May 11, 2027

Current

$54.00

Baseline

High

$78.75

▲

45.83%

Avg

$63.17

▲

16.98%

Low

$33.43

▼

-38.09%

Analyst Ratings based on 36 Analysts

Strong Buy

17%

Buy

22%

Hold

56%

Sell

06%

Strong Sell

00%

About

Stock News

View All Updates